rs2126709
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common on affy axiom data |
| Make rs2126709(C;T) |
| Make rs2126709(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 11 |
| Position | 123725219 |
| Gene | ZNF202 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2126709 |
| dbSNP (classic) | rs2126709 |
| ClinGen | rs2126709 |
| ebi | rs2126709 |
| HLI | rs2126709 |
| Exac | rs2126709 |
| Gnomad | rs2126709 |
| Varsome | rs2126709 |
| LitVar | rs2126709 |
| Map | rs2126709 |
| PheGenI | rs2126709 |
| Biobank | rs2126709 |
| 1000 genomes | rs2126709 |
| hgdp | rs2126709 |
| ensembl | rs2126709 |
| geneview | rs2126709 |
| scholar | rs2126709 |
| rs2126709 | |
| pharmgkb | rs2126709 |
| gwascentral | rs2126709 |
| openSNP | rs2126709 |
| 23andMe | rs2126709 |
| SNPshot | rs2126709 |
| SNPdbe | rs2126709 |
| MSV3d | rs2126709 |
| GWAS Ctlg | rs2126709 |
| GMAF | 0.07025 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 19875103 ]
|
| Trait | Response to antipsychotic therapy (extrapyramidal side effects) |
| Title | Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects |
| Risk Allele | |
| P-val | 4E-7 |
| Odds Ratio | NR NR |
[PMID 21162693] Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
